Good research practices for measuring drug costs in cost-effectiveness analyses: A managed care perspective: The ISPOR drug cost task force report - Part III

Value in Health

Volumn 13, Issue 1, 2010, Pages 14-17

  Mansley, Edward C ^a   Carroll, Norman V ^b   Chen, Kristina S ^c   Shah, Nilay D ^d   Piech, Catherine Tak ^e   Hay, Joel W ^f   Smeeding, James ^g  

^a MERCK RESEARCH LABORATORIES   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c ANALYSIS GROUP   (United States)

^d MAYO CLINIC   (United States)

^e CENTOCOR INC   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g JestaRx Group   (United States)

Author keywords

Cost effectiveness analysis; Costs; Drug costs; Economic analysis; Managed care

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DRUG COST; HUMAN; MANAGED CARE ORGANIZATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICARE; PRIORITY JOURNAL; REVIEW;

EID: 72949094892     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00661.x     Document Type: Article

References (18)

1. Folland S, Goodman AC, Stano M. The Economics of Health and Health Care 5th ed.). Upper Saddle River, NJ : Pearson Prentice Hall, 2007.
2. Nash DB. The Managed Care Manual. Boston : TLC Medical Publishing, 1997.
3. Berger L, Bingefors K, Hedblom E, et al., eds. Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms. Princeton, NJ : International Society for Pharmacoeconomics and Outcomes Research, 2003.
4. Congressional Budget Office. Prescription Drug Pricing in the Private Sector. Washington, DC : Congressional Budget Office, 2007.
5. AMCP Task Force on Drug Payment Methodologies. AMCP Guide to Pharmaceutical Payment Methods. Alexandria, VA : Academy of Managed Care Pharmacy, 2007.
6. Pharmacy Benefit Management Institute. The Takeda Prescription Drug Benefit Cost & Plan Design Survey Report: 2008-2009 Edition. Scottsdale, AZ : Pharmacy Benefit Management Institute, Inc., 2008.
7. Claxton G, DiJulio B, Finder B, et al. Employer Health Benefits: 2007 Annual Survey. Menlo Park, CA : Henry J. Kaiser Family Foundation, 2007.
8. Wroblewski M, Schmidt D, Schultheiss P, et al. Pharmacy Benefit Managers: Ownership of Mail-Order Pharmacies. Washington, DC : Federal Trade Commission, 2005.
9. Health Strategies Group. Best Practices, Reimbursement and Contracting Outlook 2007. Lambertville, NJ : Health Strategies Group, 2005.
10. Smith C. Retail prescription drug spending in the National Health Accounts. Health Aff 2004 23 : 161 167.
11. Office of the Inspector General. Medicaid Pharmacy - Actual Acquisition Cost of Generic Prescription Drug Products A-06-01-00053. Washington, DC : Department of Health and Human Services, 2002.
12. Gencarelli DM. Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism? NHPF Issue Brief 2002 1 19.
13. Gencarelli DM. One pill, many prices: variation in prescription drug prices in selected government programs. NHPF Issue Brief 2005 1 20.
14. Centers for Medicare and Medicaid Services. Overview Medicare Part B drug average sales price. Center for Medicare and Medicaid Services Website, 2009. Available from: http://www.cms.hhs.gov/mcrpartbdrugavgsalesprice/ [Accessed September 24, 2009 ed.). Rockland, MA : EMD Serono, Inc., 2008.
15. Mullen P. The arrival of average sales price. Biotechnol Healthc 2007 4 : 48 53.
16. Butcher L. Insurers and oncologists forge a better cancer drug policy. Manag Care 2008 17 : 28 30.
17. Paul R. Bracing for a showdown. Drug Topics 2008 152 : 30 7.
18. Latebreakers: AWP is back from the dead. Drug Topics 2008 152 : 8.